T1	CHEM 27 35	dipirona
#1	AnnotatorNotes T1	C0012586; dipyrone; Organic Chemical · Pharmacologic Substance | C3714569; metamizole sodium; Organic Chemical · Pharmacologic Substance
T2	CHEM 36 46	meperidina
#2	AnnotatorNotes T2	C0025376; meperidine; Organic Chemical · Pharmacologic Substance
T3	CHEM 76 83	opioide
#3	AnnotatorNotes T3	C0242402; Opioids; Hazardous or Poisonous Substance · Organic Chemical · Pharmacologic Substance | C0376196; Opiates; Hazardous or Poisonous Substance · Organic Chemical · Pharmacologic Substance
T4	DISO 87 98	dolor agudo
#4	AnnotatorNotes T4	C0184567; Acute onset pain; Sign or Symptom
T5	PROC 111 128	cirugía abdominal
#5	AnnotatorNotes T5	C0198482; Operation on abdominal region; Therapeutic or Preventive Procedure
T6	PROC 201 213	intervenidos
#6	AnnotatorNotes T6	C0543467; Operative Surgical Procedures; Therapeutic or Preventive Procedure
T7	DISO 220 246	dolor agudo postoperatorio
#7	AnnotatorNotes T7	C2215257; Postoperative Pain, Acute; Sign or Symptom
T8	CHEM 267 275	opioides
#8	AnnotatorNotes T8	C0242402; Opioids; Hazardous or Poisonous Substance · Organic Chemical · Pharmacologic Substance | C0376196; Opiates; Hazardous or Poisonous Substance · Organic Chemical · Pharmacologic Substance
T9	CHEM 284 292	fármacos
#9	AnnotatorNotes T9	C0013227; Pharmaceutical Preparations; Pharmacologic Substance | C0456386; Medicament; Pharmacologic Substance
T10	DISO 322 341	efectos secundarios
#10	AnnotatorNotes T10	C0041755; Adverse reaction to drug; Pathologic Function | C0559546; Adverse reactions; Pathologic Function | C0879626; Adverse effects; Pathologic Function
T11	CHEM 467 475	dipirona
#11	AnnotatorNotes T11	C0012586; dipyrone; Organic Chemical · Pharmacologic Substance | C3714569; metamizole sodium; Organic Chemical · Pharmacologic Substance
T12	CHEM 546 554	dipirona
#12	AnnotatorNotes T12	C0012586; dipyrone; Organic Chemical · Pharmacologic Substance | C3714569; metamizole sodium; Organic Chemical · Pharmacologic Substance
T13	DISO 674 690	efectos adversos
#13	AnnotatorNotes T13	C0041755; Adverse reaction to drug; Pathologic Function | C0559546; Adverse reactions; Pathologic Function | C0879626; Adverse effects; Pathologic Function
T14	CHEM 731 739	dipirona
#14	AnnotatorNotes T14	C0012586; dipyrone; Organic Chemical · Pharmacologic Substance | C3714569; metamizole sodium; Organic Chemical · Pharmacologic Substance
T15	CHEM 745 755	meperidina
#15	AnnotatorNotes T15	C0025376; meperidine; Organic Chemical · Pharmacologic Substance
T16	CHEM 794 801	opioide
#16	AnnotatorNotes T16	C0242402; Opioids; Hazardous or Poisonous Substance · Organic Chemical · Pharmacologic Substance | C0376196; Opiates; Hazardous or Poisonous Substance · Organic Chemical · Pharmacologic Substance
T17	DISO 826 852	dolor agudo postoperatorio
#17	AnnotatorNotes T17	C2215257; Postoperative Pain, Acute; Sign or Symptom
T18	CHEM 986 996	meperidina
#18	AnnotatorNotes T18	C0025376; meperidine; Organic Chemical · Pharmacologic Substance
T19	CHEM 1010 1018	dipirona
#19	AnnotatorNotes T19	C0012586; dipyrone; Organic Chemical · Pharmacologic Substance | C3714569; metamizole sodium; Organic Chemical · Pharmacologic Substance
T20	CHEM 1062 1072	meperidina
#20	AnnotatorNotes T20	C0025376; meperidine; Organic Chemical · Pharmacologic Substance
T21	DISO 1097 1123	dolor agudo postoperatorio
#21	AnnotatorNotes T21	C2215257; Postoperative Pain, Acute; Sign or Symptom
T22	PROC 1140 1161	escala visual análoga
#22	AnnotatorNotes T22	C0042815; Visual Analog Pain Scale; Diagnostic Procedure | C2959685; Assessment using visual analog scale; Health Care Activity
T23	DISO 1194 1220	dolor agudo postoperatorio
#23	AnnotatorNotes T23	C2215257; Postoperative Pain, Acute; Sign or Symptom
T24	PROC 1245 1256	intervenido
#24	AnnotatorNotes T24	C0543467; Operative Surgical Procedures; Therapeutic or Preventive Procedure
T25	PROC 1331 1342	intervenido
#25	AnnotatorNotes T25	C0543467; Operative Surgical Procedures; Therapeutic or Preventive Procedure
T26	DISO 1420 1439	efectos secundarios
#26	AnnotatorNotes T26	C0041755; Adverse reaction to drug; Pathologic Function | C0559546; Adverse reactions; Pathologic Function | C0879626; Adverse effects; Pathologic Function
T27	CHEM 1571 1579	dipirona
#27	AnnotatorNotes T27	C0012586; dipyrone; Organic Chemical · Pharmacologic Substance | C3714569; metamizole sodium; Organic Chemical · Pharmacologic Substance
T28	CHEM 1584 1594	meperidina
#28	AnnotatorNotes T28	C0025376; meperidine; Organic Chemical · Pharmacologic Substance
T29	CHEM 1641 1648	opioide
#29	AnnotatorNotes T29	C0242402; Opioids; Hazardous or Poisonous Substance · Organic Chemical · Pharmacologic Substance | C0376196; Opiates; Hazardous or Poisonous Substance · Organic Chemical · Pharmacologic Substance
T30	DISO 1660 1676	efectos adversos
#30	AnnotatorNotes T30	C0041755; Adverse reaction to drug; Pathologic Function | C0559546; Adverse reactions; Pathologic Function | C0879626; Adverse effects; Pathologic Function
T31	PROC 1689 1727	control del dolor agudo postoperatorio
T32	DISO 1701 1727	dolor agudo postoperatorio
#31	AnnotatorNotes T32	C2215257; Postoperative Pain, Acute; Sign or Symptom
T33	ANAT 119 128	abdominal
#32	AnnotatorNotes T33	C0000726; Abdomen; Body Location or Region | C1281594; Entire abdomen; Body Part, Organ, or Organ Component
T34	CHEM 558 568	meperidina
#33	AnnotatorNotes T34	C0025376; meperidine; Organic Chemical · Pharmacologic Substance
T35	PROC 882 907	ensayo clínico controlado
#34	AnnotatorNotes T35	C0206035; Controlled Clinical Trials, Randomized; Research Activity
T36	LIVB 177 186	pacientes
#35	AnnotatorNotes T36	C0030705; Patients; Patient or Disabled Group
T37	Time 232 246	postoperatorio
#36	AnnotatorNotes T37	C0032790; Postoperative Period; Temporal Concept
T38	LIVB 431 440	cirujanos
#37	AnnotatorNotes T38	C0582175; Surgeon; Professional or Occupational Group
T40	LIVB 640 664	médicos no especialistas
#38	AnnotatorNotes T40	C0017319; General Practitioners; Professional or Occupational Group
T41	Neg_cue 666 669	sin
T43	Time 838 852	postoperatorio
#39	AnnotatorNotes T43	C0032790; Postoperative Period; Temporal Concept
T44	LIVB 916 925	pacientes
#40	AnnotatorNotes T44	C0030705; Patients; Patient or Disabled Group
T45	Dose 973 982	0,5 mg/kg
T46	Dose 1001 1006	2,5 g
T47	Dose 1076 1083	1 mg/kg
T48	Time 1109 1123	postoperatorio
#41	AnnotatorNotes T48	C0032790; Postoperative Period; Temporal Concept
T49	Time 1206 1220	postoperatorio
#42	AnnotatorNotes T49	C0032790; Postoperative Period; Temporal Concept
T51	LIVB 1239 1256	grupo intervenido
#43	AnnotatorNotes T51	C2986530; Intervention Group; Population Group | C5205743; Experimental Group; Population Group
T53	LIVB 1481 1494	grupo control
#44	AnnotatorNotes T53	C0009932; Control Groups; Group
T55	Time 1713 1727	postoperatorio
#45	AnnotatorNotes T55	C0032790; Postoperative Period; Temporal Concept
T57	LIVB 407 424	médicos generales
#46	AnnotatorNotes T57	C0017319; General Practitioners; Professional or Occupational Group
T39	LIVB 1276 1283	control
#47	AnnotatorNotes T39	C0009932; Control Groups; Group
T42	LIVB 1325 1342	grupo intervenido
#48	AnnotatorNotes T42	C2986530; Intervention Group; Population Group | C5205743; Experimental Group; Population Group
A1	Assertion T13 Negated
R1	Negation Arg1:T41 Arg2:T13	
T50	Neg_cue 1678 1681	sin
T52	Quantifier_or_Qualifier 1732 1738	eficaz
A2	Assertion T52 Negated
R2	Has_Quantifier_or_Qualifier Arg1:T31 Arg2:T52	
R3	Negation Arg1:T50 Arg2:T52	
T54	Neg_cue 1374 1377	sin
T56	CONC 1378 1389	diferencias
A3	Assertion T56 Negated
#49	AnnotatorNotes T56	C1705241; Delta (difference); Quantitative Concept
R4	Negation Arg1:T54 Arg2:T56	
#50	AnnotatorNotes T52	C1704419; Effective; Qualitative Concept
T58	Spec_cue 524 529	sería
T59	CONC 533 540	adición
A4	Assertion T59 Speculated
R5	Speculation Arg1:T58 Arg2:T59	
R6	Combined_with Arg1:T12 Arg2:T34	
A5	Assertion T12 Speculated
A6	Assertion T34 Speculated
R7	Speculation Arg1:T58 Arg2:T12	
R8	Speculation Arg1:T58 Arg2:T34	
R9	Combined_with Arg1:T1 Arg2:T2	
R11	After Arg1:T4 Arg2:T5	
R12	Location_of Arg1:T33 Arg2:T5	
R13	Experiences Arg1:T36 Arg2:T6	
R14	Causes Arg1:T6 Arg2:T7	
R15	Overlap Arg1:T7 Arg2:T37	
R18	Experiences Arg1:T36 Arg2:T7	
R19	Experiences Arg1:T36 Arg2:T8	
R20	Experiences Arg1:T36 Arg2:T9	
R21	Causes Arg1:T9 Arg2:T10	
R22	Causes Arg1:T8 Arg2:T10	
R23	Before Arg1:T34 Arg2:T13	
R24	Before Arg1:T12 Arg2:T13	
R25	Combined_with Arg1:T14 Arg2:T15	
R26	Overlap Arg1:T16 Arg2:T17	
R27	Overlap Arg1:T17 Arg2:T43	
R28	Combined_with Arg1:T18 Arg2:T19	
R29	Has_Dose_or_Strength Arg1:T19 Arg2:T46	
R30	Has_Dose_or_Strength Arg1:T18 Arg2:T45	
R31	Has_Dose_or_Strength Arg1:T20 Arg2:T47	
R32	Overlap Arg1:T21 Arg2:T48	
R33	Overlap Arg1:T22 Arg2:T48	
R34	Overlap Arg1:T23 Arg2:T49	
R35	Experiences Arg1:T51 Arg2:T23	
R36	Experiences Arg1:T51 Arg2:T24	
R37	Causes Arg1:T24 Arg2:T23	
R38	Experiences Arg1:T39 Arg2:T24	
R39	Experiences Arg1:T39 Arg2:T23	
T60	CONC 1288 1303	riesgo relativo
#51	AnnotatorNotes T60	C0242492; Relative Risk; Quantitative Concept
T61	CONC 1305 1307	RR
#52	AnnotatorNotes T61	C0242492; Relative Risk; Quantitative Concept
R40	Experiences Arg1:T42 Arg2:T25	
T62	CONC 1457 1474	riesgos absolutos
#53	AnnotatorNotes T62	C1519101; Risk Estimate; Quantitative Concept (?)
R41	Experiences Arg1:T53 Arg2:T26	
R42	Combined_with Arg1:T27 Arg2:T28	
R43	Causes Arg1:T29 Arg2:T30	
R44	Overlap Arg1:T32 Arg2:T55	
R45	Overlap Arg1:T31 Arg2:T32	
T63	Spec_cue 714 716	si
T64	CONC 756 765	disminuye
A7	Assertion T64 Speculated
#54	AnnotatorNotes T64	C0547047; Decrease; Quantitative Concept
R10	Speculation Arg1:T63 Arg2:T64	
A8	Experiencer T53 Patient
A9	Experiencer T42 Patient
A10	Experiencer T39 Patient
A11	Experiencer T51 Patient
A12	Experiencer T44 Patient
A13	Experiencer T40 Other
A14	Experiencer T38 Other
A15	Experiencer T57 Other
A16	Experiencer T36 Patient
A17	Status T6 Future
A18	Status T7 Future
